NEWS
Slater Technology Fund Year in Review
Powered by a new contract to manage capital from CommerceRI, Slater posted over $2.3 million in ten companies
Lenoss Oversubscribes $4 Million Series A Financing
Funding will accelerate commercialization and fuel innovative product development
Slater Invests in Octagon Therapeutics Seed Round
Octagon is developing new medicines for autoimmune disease based on selective immunomodulation.
Bolden Announces $1.5M Pre-Seed Financing
Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis.
Lenoss Medical: All Things OsteoPearl
Ingenuity lies in simplicity. Our Q&A with Lenoss Medical Founder & CEO, Dom Messerli
MindImmune Appoints Industry Leaders to Board
Brad Margus and Robert Michael Poole, MD FACP, bring deep background and experience
Slater to oversee $12M for Rhode Island venture development
Venture efforts will get $12 million in federal funding via a new agreement.
Rhode Island Commerce Awards Slater $12M for Venture Development
VC Firm Receives SSBCI Funding for Second Time
Brown-launched biotech secures $375,000 in Slater funding
XM Therapeutics seeks to develop new treatments for chronic heart and pulmonary conditions.
Slater Invests in XM Therapeutics from Brown University
Biotech targeting heart failure and pulmonary fibrosis comes out of stealth.
Faculty inventions, startups shine at Innovation@Brown Showcase
Business leaders, investors and entrepreneurs convened in Providence to connect with Brown scientists.
State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience
More entrepreneurs are launching companies and putting down roots in the Ocean State.
RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company
New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment for Neuroinflammatory Conditions Such as Alzheimer’s Disease
Noted Scientist Nancy Ryan Gray and Brown University Engineering Dean Lawrence Larson Join the Slater Board
New appointees bring critical insight into the commercialization of university-based research.
There’s a New Implant Developed in Rhode Island to Treat Spine Fractures
Using special instrumentation these Osteo-Pearls are implanted into the fractured vertebrae.
RightHill Ventures Launches to Accelerate the Journey from Research to Startup for University Innovations
Beginning with innovations from Brown University researchers, new fund will build companies from university discoveries.
Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy
Arctura has won a $1.15-million grant from the U.S. Dept. of Energy to commercialize a new blade coating designed to reduce the damage to wind turbine blades caused by lightning.
Slater-Backed Company Acquired by Novartis
Cadent Therapeutics has entered into an agreement to be acquired by global healthcare giant Novartis [NYSE: NVS] in a deal worth up to $770 million.
$597,500 in EDA Grants for Slater Technology Fund, RI Bio Will Boost Health Care Startups in Rhode Island
Federal grants will launch new partnership to support translational research companies and a program to grow life science startups.
Slater Technology Fund Establishes Its Third Special-Purpose Fund to Invest in HappyNest
HappyNest is a technology-enabled laundry pickup and delivery service expanding nationwide from its headquarters in Rhode Island.
Slater Technology Fund Invests in Pharmaceutical Startup Developing Novel Cancer Therapeutics
URI-based company is developing promising new synthetic molecules for use in treating ovarian cancer.
Slater Technology Fund Leads Other Investors in a $250,000 Seed Round in Laundry-as-a-Service Company
HappyNest seeks to disrupt the $40 Billion laundry industry.
Slater Technology Fund Closes on $25,000 Investment in EdTech Startup
GoPeer is building a technology platform to streamline the effort and expense associated with K-12 tutoring.
